TrialInflammopharmacology2018

A phase I/II randomized, controlled, clinical trial for assessment of the efficacy and safety of β-D-mannuronic acid in rheumatoid arthritis patients.

Hossein Ahmadi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.